Qingyun Long
About
In The Last Decade
Qingyun Long
21 papers receiving 453 citations
Peers
Comparison fields: 5 of 72
- Hepatology 134
- Radiology, Nuclear Medicine and Imaging 125
- Infectious Diseases 90
- Pulmonary and Respiratory Medicine 82
- Epidemiology 76
Countries citing papers authored by Qingyun Long
This map shows the geographic impact of Qingyun Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyun Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyun Long more than expected).
Fields of papers citing papers by Qingyun Long
This network shows the impact of papers produced by Qingyun Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyun Long. The network helps show where Qingyun Long may publish in the future.
Co-authorship network of co-authors of Qingyun Long
This figure shows the co-authorship network connecting the top 25 collaborators of Qingyun Long. A scholar is included among the top collaborators of Qingyun Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyun Long. Qingyun Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Mechanism of astragalus injection to relieve symptoms of preeclampsia rat model by inhibiting MMP-9/sFlt-1/TNF-α. | 2 |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 33 | |
| 7 | 179 | |
| 8 | 10 | |
| 9 | 10 | |
| 10 | 4 | |
| 11 | 7 | |
| 12 | Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients. | 30 |
| 13 | 6 | |
| 14 | 78 | |
| 15 | 2 | |
| 16 | 27 | |
| 17 | 6 | |
| 18 | 6 | |
| 19 | 19 | |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.